Welcome to MyStrategist, the digital home for Market Pathways.

Market Pathways covers the people, challenges, and opportunities impacting the global medtech regulatory, reimbursement, and policy communities. We invite you to explore our coverage. Think Strategically. Subscribe Today

Browse   Latest Issue

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review


Pathways' Picks

Diagnostics Updates, AI Advocacy, China Documents, and More

In this week’s Pathways Picks: Members of Congress push against FDA’s lab-developed test rule; Australia updates companion diagnostic resources; AI updates from Europe and the US; Guidance documents from US FDA and China NMPA; EPA rule; and more from Australia and the US.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Regulatory & Reimbursement

Making Your Voice Heard in Regulatory Affairs With Hasnaa Fatehi

Regulatory professionals are sometimes sidelined within companies, and labeled as barriers to innovation and profit. In this edition of Consultants Corner, QARALOGIC’s Hasnaa Fatehi discusses how regulatory affairs specialists can better frame their role in the context of a company’s commercial priorities and be relied on as a partner in market success.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review


Pathways' Picks

Dx Debate, Medicare Diabetes Endpoints, EU Expert Panels, and Global Picks

In this week’s Pathways Picks: Congress faces lab-developed test conundrum; FDA retries device ban; CMS works on diabetes device endpoints guidance; selective EU device expert panels; HTA guidelines; Brazil adds to MDSAP benefits; Kenya, Jordan, and Mexico join IMDRF, and more from the US, UK, and China.

Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.

Subscribe Now   Learn More